Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa.

Current Opinion in HIV and AIDS
Anna Kramvis

Abstract

The aim of this article is to highlight the unique challenges for hepatitis B virus (HBV) cure faced in resource-limited settings (RLS) in sub-Saharan Africa (SSA), where access to disease prevention measures, medical testing, and treatment are limited. SSA RLS face challenges, which need to be anticipated as HBV cure research advances. There is a paucity of data because of lack of HBV surveillance and limited access to laboratories. Interruption of transfusion-transmitted infections, perinatal mother-to-child-transmissions, and transmission in people-who-infect-drug networks has not been achieved fully. Although RLS in SSA are within the epicenter of the HIV pandemic, unlike for HIV, there is no population-based testing for HBV. Public health response to HBV is inadequate with concomitant political inertia in combatting HBV infection. A functional HBV cure will improve the diagnosis/treatment cascade, decrease costs and accelerate HBV elimination. There is a concerted effort to find a HBV cure, which will be finite, not require life-long treatment, adherence, and continued monitoring. Increased research, improved financial, infrastructural and human resources will positively impact on implementation of HBV cure, when available...Continue Reading

References

Aug 4, 2004·The Lancet Infectious Diseases·S K ObaroK Luzuriaga
Sep 7, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yasuhito TanakaMasashi Mizokami
Jul 14, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Anna Kramvis, Michael C Kew
Jul 14, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Anna Kramvis, Michael C Kew
May 6, 2008·Lancet·Richard J Lessells, Graham S Cooke
Oct 22, 2009·Transfusion·Sudha JayaramanIan Roberts
Apr 5, 2011·Lancet·Deepak JoshiKosh Agarwal
Jun 26, 2013·Antiviral Therapy·Anna Kramvis, Dimitrios Paraskevis
Aug 24, 2013·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·C W N SpearmanUNKNOWN Division of Hepatology, Department of Medicine, University of Cape Town, South Africa
Feb 25, 2014·The International Journal on Drug Policy·Nick WalshElie A Akl
Jun 30, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Philippa C MatthewsPaul Klenerman
Jul 19, 2014·Intervirology·Anna Kramvis
Dec 3, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hatim MudawiAnna Kramvis
Jun 20, 2015·The Lancet Global Health·Monique I AnderssonCharles Wiysonge
Aug 5, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T Jake LiangAnna S Lok
Jan 8, 2016·The Lancet Infectious Diseases·Yusuke ShimakawaMaud Lemoine
Mar 10, 2016·European Journal of Gastroenterology & Hepatology·Julie BotteroKarine Lacombe
May 4, 2016·Reviews in Medical Virology·Anna Kramvis
Sep 7, 2016·Journal of Hepatology·Jördis J OttRafael T Mikolajczyk
Sep 18, 2016·The Lancet Infectious Diseases·Shevanthi NayagamTimothy B Hallett
Nov 17, 2016·Gut·Jeremy SugarmanSharon R Lewin
Jan 13, 2017·Current Opinion in HIV and AIDS·Paul K Drain, Christine Rousseau
Mar 18, 2017·Current Opinion in HIV and AIDS·Philippa J EasterbrookRosanna Peeling
Aug 2, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S LokMarc G Ghany
Oct 27, 2017·Infectious Diseases and Therapy·Joop E ArendsAndrew Ustianowski
Mar 31, 2018·The Lancet. Gastroenterology & Hepatology·UNKNOWN Polaris Observatory Collaborators
Apr 11, 2018·Journal of the International AIDS Society·Anders BoydKarine Lacombe
May 26, 2018·Journal of Hepatology·Stéphane Chevaliez, Jean-Michel Pawlotsky
Jul 28, 2018·Nature Reviews. Gastroenterology & Hepatology·Jeffrey V LazarusBenjamin C Cowie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.